NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
Clinical Trials
61 trialsNCT04897763 2026-01-07
PERTINENCE
Institut Cancerologie de l'Ouest
Phase EARLY_PHASE1 Completed
NCT03734653 2025-11-06
Testosterone Therapy in Castration Resistant Prostate Cancer
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT03507608 2025-10-16
Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT06520449 2025-09-25
NTA-476
Melbourne Theranostic Innovation Centre
Phase EARLY_PHASE1 Completed
NCT04576871 2025-08-28
Re-treatment 225Ac-J591 for mCRPC
Weill Medical College of Cornell University
Phase EARLY_PHASE1 Completed
NCT03039413 2025-08-22
Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT04301414 2025-08-07
Neo-Red-P
Columbia University
Phase EARLY_PHASE1 Completed
NCT03987217 2025-05-14
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients
University of Utah
Phase EARLY_PHASE1 Completed
NCT03661437 2025-04-11
Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy
City of Hope Medical Center
Phase EARLY_PHASE1 Completed
NCT02420977 2025-03-19
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT05110495 2025-02-17
WINGMEN
University of Oxford
Phase EARLY_PHASE1 Completed
NCT06359821 2025-02-14
Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer
Sichuan University
Phase EARLY_PHASE1 Completed
NCT03473730 2025-01-30
Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT03232164 2024-12-12
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT01868087 2024-11-01
Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT02952469 2024-09-03
Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC
University of Iowa
Phase EARLY_PHASE1 Completed
NCT04067960 2024-08-14
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT02113657 2024-05-24
T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT04752267 2024-05-24
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
University of Southern California
Phase EARLY_PHASE1 Completed
NCT03358563 2024-05-03
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT04726033 2024-05-01
CUPID
Telix Pharmaceuticals (Innovations) Pty Limited
Phase EARLY_PHASE1 Completed
NCT05725070 2023-10-06
Phase 0/1 Study of 212Pb-NG001 in mCRPC
ARTBIO Inc.
Phase EARLY_PHASE1 Completed
NCT01253213 2023-08-01
BR55 in Prostate Cancer: an Exploratory Clinical Trial
Bracco Diagnostics, Inc
Phase EARLY_PHASE1 Completed
NCT02391025 2023-06-18
Gallium-68 Citrate PET Used in Prostate Cancer
University of California, San Francisco
Phase EARLY_PHASE1 Completed
NCT04158817 2023-04-18
68Ga-THP-PSMA PET/CT in Prostate Cancer: Clinical Stage and Restage
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Completed
NCT04282967 2023-04-11
Streaming Web-based Exercise At Home: A Pilot Study
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Completed
NCT04976257 2023-04-07
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion
University of California, San Francisco
Phase EARLY_PHASE1 Completed
NCT02534376 2023-02-22
Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Completed
NCT05728515 2023-02-15
A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Completed
NCT02826382 2023-01-12
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Five Eleven Pharma, Inc.
Phase EARLY_PHASE1 Completed
NCT03204266 2022-08-24
Oral Supplementation to Enhance Recovery Pilot Study
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT02626130 2022-07-07
Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT02715583 2022-05-18
C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
NCT04266392 2022-05-05
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand
Stony Brook University
Phase EARLY_PHASE1 Completed
NCT03071328 2022-04-11
INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers
Duke University
Phase EARLY_PHASE1 Completed
NCT04804163 2022-02-16
Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery
The Affiliated Hospital of Qingdao University
Phase EARLY_PHASE1 Completed
NCT01738815 2021-10-22
Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
State University of New York - Upstate Medical University
Phase EARLY_PHASE1 Completed
NCT01434342 2021-09-28
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT04060043 2021-05-10
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer
CMX Research
Phase EARLY_PHASE1 Completed
NCT02753309 2021-03-19
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT04282824 2020-12-02
MSG PSMA PET
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT02357121 2020-09-21
FLA
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT01221506 2020-03-26
Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
NCT00214422 2019-07-19
Intensity Modulated Radiation Therapy for Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT02729194 2019-06-10
Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT02646319 2019-06-06
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT02190279 2019-04-23
18F-DCFBC PET/CT in Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT02115828 2018-07-20
A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT01778933 2018-07-03
Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17)
University of Pennsylvania
Phase EARLY_PHASE1 Completed